Crizanlizumab Biosimilar - Research Grade

Crizanlizumab Biosimilar - Research Grade, Host: CHO Cells, Human IgG2 (P189T/V282M/K322A/S378A)-kappa
Artikelnummer
ICH5300-100mg
Verpackungseinheit
100mg
Hersteller
Ichorbio

Verfügbarkeit: wird geladen...
Preis wird geladen...
Target: SELP

Specificity: Detects human SELP

Purification method: This monoclonal antibody was purified using Protein A

Concentration: 5mg/ml

Formulation: Sterile, preservative-free, solution in PBS. BSA and Azide free.

Purity: >95% by SDS-PAGE

Endotoxin: ≤ 1.0 EU/mg as determined by the LAL method

Use: Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Mehr Informationen
Artikelnummer ICH5300-100mg
Hersteller Ichorbio
Hersteller Artikelnummer ICH5300-100mg
Verpackungseinheit 100mg
Mengeneinheit STK
Reaktivität Human
Klonalität Monoclonal
Methode Functional Assay
Isotyp Human IgG2 (P189T/V282M/K322A/S378A)-kappa
Wirt Cell Line
Produktinformation (PDF)
×
MSDS (PDF) Download